Device Trial Radar · NCT03413085
To Evaluate the Efficacy and Safety of Multifocal Soft Contact Lens in Myopia Control
Last checked: Nov 20, 2026Latest source record: Mar 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
59
Actual
Start
May 2, 2018
Primary completion
Dec 31, 2019
Study completion Mar 5, 2020
Sponsor
- Lead sponsor
- Largan Medical Co., Ltd.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- National Taiwan University Hospital; Chang Gung Memorial Hospital
- First posted
- Jan 29, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 6 years, up to 15 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is to investigate the efficacy and safety of soft lens in myopia control.
Conditions
- Myopia
Interventions
soft contact lensDevice
Group A Group B
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective cycloplegic refractive errorTime frame: 48 weeks
1 more outcomes with a free account
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Tzu-Hsun Tsai M.D.
Taipei, Taiwan
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.